Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1716 ARTÍCULOS , VIENDO DEL 916 AL 930

Optical Imaging of Beta-Amyloid Plaques in Alzheimer's Disease

Luo Z, Xu H, Liu L, Ohulchanskyy TY, Qu J.

Biosensors (Basel). 2021 Jul 29;11(8):255. doi: 10.3390/bios11080255.

The Utility of Next-Generation Sequencing for Identifying the Genetic Basis of Dementia

Klimkowicz-Mrowiec A, Dziubek A, Sado M, Karpiński M, Gorzkowska A.

Int J Environ Res Public Health. 2021 Aug 12;18(16):8520. doi: 10.3390/ijerph18168520.

Involvement of cerebrovascular abnormalities in the pathogenesis and progression of Alzheimer's disease: an adrenergic approach

Li S, Wang C, Wang Z, Tan J.

Aging (Albany NY). 2021 Sep 3;13(17):21791-21806. doi: 10.18632/aging.203482. Epub 2021 Sep 3.

Dosimetry and Clinical Efficacy of Transcranial Photobiomodulation for Major Depression Disorder: Could they Guide Dosimetry for Alzheimer's Disease?

Caldieraro MA, Laufer-Silva T, Cassano P.

J Alzheimers Dis. 2021;83(4):1453-1469. doi: 10.3233/JAD-210586.

Evolution of genetic testing supports precision medicine for caring Alzheimer's disease patients

Bruni AC, Bernardi L, Maletta R.

Curr Opin Pharmacol. 2021 Oct;60:275-280. doi: 10.1016/j.coph.2021.08.004. Epub 2021 Sep 3.

Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease

Radaghdam S, Karamad V, Nourazarian A, Shademan B, Khaki-Khatibi F, Nikanfar M.

Neurosci Lett. 2021 Nov 1;764:136221. doi: 10.1016/j.neulet.2021.136221. Epub 2021 Sep 6.

Diagnostic performance of the medial temporal lobe atrophy scale in patients with Alzheimer's disease: a systematic review and meta-analysis

Park HY, Park CR, Suh CH, Shim WH, Kim SJ.

Eur Radiol. 2021 Dec;31(12):9060-9072. doi: 10.1007/s00330-021-08227-8. Epub 2021 Sep 11.

A Systematic Review of Expressive and Receptive Prosody in People With Dementia

Oh C, Morris RJ, Wang X.

J Speech Lang Hear Res. 2021 Oct 4;64(10):3803-3825. doi: 10.1044/2021_JSLHR-21-00013. Epub 2021 Sep 16.

Aducanumab (Aduhelm) for Alzheimer's disease

Med Lett Drugs Ther. 2021 Jul 12;63(1628):105-106.

Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views

Kanel P, Bedard MA, Aghourian M, Rosa-Neto P, Soucy JP, Albin RL, Bohnen NI.

Curr Neurol Neurosci Rep. 2021 Sep 20;21(10):52. doi: 10.1007/s11910-021-01140-z.

Breakdown of specific functional brain networks in clinical variants of Alzheimer's disease

Pini L, Wennberg AM, Salvalaggio A, Vallesi A, Pievani M, Corbetta M.

Ageing Res Rev. 2021 Dec;72:101482. doi: 10.1016/j.arr.2021.101482. Epub 2021 Oct 2.

Serum aberrant expression of miR-24-3p and its diagnostic value in Alzheimer's disease

Liu L, Liu L, Lu Y, Zhang T, Zhao W.

Biomark Med. 2021 Nov;15(16):1499-1507. doi: 10.2217/bmm-2021-0098. Epub 2021 Oct 20.

Chinese expert consensus statement for diagnosis and treatment of dementia with Lewy bodies 2020

Ji Y, Li YF, Peng DT, Chen ZC; Chinese Society of Geriatrics of Chinese Medical Association, Chinese Society of Microcirculation Neurodegenerative Diseases Committee.

Chin Med J (Engl). 2021 Oct 20;134(21):2529-2531. doi: 10.1097/CM9.0000000000001754.

d-Amino Acids and pLG72 in Alzheimer's Disease and Schizophrenia

Cheng YJ, Lin CH, Lane HY.

Int J Mol Sci. 2021 Oct 9;22(20):10917. doi: 10.3390/ijms222010917.

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators.

Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias